Cargando…

Identification of FPR3 as a Unique Biomarker for Targeted Therapy in the Immune Microenvironment of Breast Cancer

Although research into immunotherapy is growing, its use in the treatment of breast cancer remains limited. Thus, identification and evaluation of prognostic biomarkers of tissue microenvironments will reveal new immune-based therapeutic strategies for breast cancer. Using an in silico bioinformatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Jian, Liu, Yu, Hu, Jiliang, Lu, Li, Dou, Zhen, Dai, Haiming, Wang, Hongzhi, Yang, Wulin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928373/ https://www.ncbi.nlm.nih.gov/pubmed/33679387 http://dx.doi.org/10.3389/fphar.2020.593247

Ejemplares similares

Systematic expression analysis of WEE family kinases reveals the importance of PKMYT1 in breast carcinogenesis
por: Liu, Yu, et al.
Publicado: (2019)

Microenvironment involved in FPR1 expression by human glioblastomas
por: Boer, J. C., et al.
Publicado: (2015)

FPR Ligands
por: Liu, Ying, et al.
Publicado: (2013)

The ambiguous role of FPR1 in immunity and inflammation
por: Vacchelli, Erika, et al.
Publicado: (2020)

Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy
por: Li, Weizhen, et al.
Publicado: (2021)

An Immune-Associated Genomic Signature Effectively Predicts Pathologic Complete Response to Neoadjuvant Paclitaxel and Anthracycline-Based Chemotherapy in Breast Cancer
por: Fu, Changfang, et al.
Publicado: (2021)

Pan-cancer analysis identifies NT5E as a novel prognostic biomarker on cancer-associated fibroblasts associated with unique tumor microenvironment
por: Xue, Xin-miao, et al.
Publicado: (2022)

Immune Intervention in Sepsis
por: Chen, Jian, et al.
Publicado: (2021)

An m6A-Related Prognostic Biomarker Associated With the Hepatocellular Carcinoma Immune Microenvironment
por: Du, Yingxi, et al.
Publicado: (2021)

Mitocryptide-2: Identification of Its Minimum Structure for Specific Activation of FPR2–Possible Receptor Switching from FPR2 to FPR1 by Its Physiological C-terminal Cleavages
por: Marutani, Takayuki, et al.
Publicado: (2021)

FPR1 is the plague receptor on host immune cells
por: Osei-Owusu, Patrick, et al.
Publicado: (2019)

Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2
por: Zhuang, Youwen, et al.
Publicado: (2022)

Identification of Immune-Related Prognostic Genes and LncRNAs Biomarkers Associated With Osteosarcoma Microenvironment
por: Zhang, Tao, et al.
Publicado: (2020)

Identification and validation of FPR1, FPR2, IL17RA and TLR7 as immunogenic cell death related genes in osteoarthritis
por: Ren, Tingting, et al.
Publicado: (2023)

Corrigendum: Identification of Immune-Related Prognostic Genes and LncRNAs Biomarkers Associated With Osteosarcoma Microenvironment
por: Zhang, Tao, et al.
Publicado: (2020)

CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?
por: Zhang, Chunxue, et al.
Publicado: (2023)

Screening and Identification of Key Biomarkers in Acquired Lapatinib-Resistant Breast Cancer
por: Bao, Shengnan, et al.
Publicado: (2020)

Exploration of the Immune-Related Long Noncoding RNA Prognostic Signature and Inflammatory Microenvironment for Cervical Cancer
por: Yao, Hui, et al.
Publicado: (2022)

Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors
por: Wen, Yang, et al.
Publicado: (2021)

Comprehensive analysis of Cuproplasia and immune microenvironment in lung adenocarcinoma
por: Kuang, Junjie, et al.
Publicado: (2023)

Tumor Microenvironment Targeted Nanotherapy
por: Fernandes, Clara, et al.
Publicado: (2018)

The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
por: Kim, Seong Keun, et al.
Publicado: (2022)

Ferroptosis-related genes are involved in asthma and regulate the immune microenvironment
por: Wang, Haixia, et al.
Publicado: (2023)

The effect of liver disease on hepatic microenvironment and implications for immune therapy
por: Brown, Zachary J., et al.
Publicado: (2023)

Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
por: Zhang, Xin, et al.
Publicado: (2023)

FPR2: A Novel Promising Target for the Treatment of Influenza
por: Alessi, Marie-Christine, et al.
Publicado: (2017)

Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer
por: Carbonnier, Vincent, et al.
Publicado: (2023)

Research Progress About Glioma Stem Cells in the Immune Microenvironment of Glioma
por: Li, Xiangyu, et al.
Publicado: (2021)

Resistance mechanisms of immune checkpoint inhibition in lymphoma: Focusing on the tumor microenvironment
por: Zhang, Chunlan, et al.
Publicado: (2023)

Targeting the Microenvironment in MDS: The Final Frontier
por: Teodorescu, Patric, et al.
Publicado: (2020)

Identification of anoikis-related molecular patterns to define tumor microenvironment and predict immunotherapy response and prognosis in soft-tissue sarcoma
por: Qi, Lin, et al.
Publicado: (2023)

Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer
por: Zhao, Wenjie, et al.
Publicado: (2021)

Environmental exposure and the role of AhR in the tumor microenvironment of breast cancer
por: Sweeney, Colleen, et al.
Publicado: (2022)

Prognostic value of a novel FPR biomarker in patients with surgical stage II and III gastric cancer
por: Zhang, Jing, et al.
Publicado: (2017)

A senescence-associated signature refines the classification of different modification patterns and characterization of tumor immune microenvironment infiltration in triple-negative breast cancer
por: Huang, Renhong, et al.
Publicado: (2023)

Modulation of Tumor Immune Microenvironment and Prognostic Value of Ferroptosis-Related Genes, and Candidate Target Drugs in Glioblastoma Multiforme
por: Zhang, Xudong, et al.
Publicado: (2022)

Identification and validation of tumor microenvironment-related prognostic biomarkers in breast cancer
por: Zhong, Shanliang, et al.
Publicado: (2021)

Targeted Inhibition of LPL/FABP4/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer
por: Yang, Haoran, et al.
Publicado: (2021)

Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2021)

Identification of lncRNA DLEU2 as a potential diagnostic biomarker and anti-inflammatory target for ulcerative colitis
por: Lin, Qiuling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bkd7i83lr3e4gog2inc13hplik